Table S1. Comparison between each data point and the posterior mean estimates, for each of

Similar documents
21/02/2018. How Far is it Acceptable to Walk? Introduction. How Far is it Acceptable to Walk?

Status Report on the Yellowstone Bison Population, September 2017 Chris Geremia, Rick Wallen, and P.J. White 1

College/high school median annual earnings gap,

2011 Census Snapshot: Method of Travel to work in London

Figure 1a. Top 1% income share: China vs USA vs France

Population Dynamics and Adaptive Management of Yellowstone Bison

European Golf Statistics 2017

SUPPLEMENTARY APPENDIX. Ary Serpa Neto MD MSc, Fabienne D Simonis MD, Carmen SV Barbas MD PhD, Michelle Biehl MD, Rogier M Determann MD PhD, Jonathan

Regulated hunting re-shapes the life history of brown bears

Cycling to work in London, 2011

1 Teaching Objective(s) *Lesson plan designed for1-2 days Mississippi Mathematics Framework The student will: 2 Instructional Activities

School of Social and Community Medicine, University of Bristol Division of Global Public Health, UC San Diego

Smoothing the histogram: The Normal Curve (Chapter 8)

Research. 20mph survey. Drivers opinions of 20mph speed limits

SEASON FINAL REGISTRATION REPORTS

Building a Healthy Boston. BOSTON PUBLIC HEALTH COMMISSION Infectious Disease Bureau Communicable Disease Control Division

Table 9 and 10 present the norms by gender and by age group, respectively. As can be

Long-term consequence of injury on self-rated health

Lewisham Pharmaceutical Needs Assessment Appendix B - Lewisham The Place

Chapter 11 TONGUE (ICD-10: C01-C02) years 2004 to 2006 is given in Table 11.1(a). Cancer of the tongue was among the five leading sites in all

A Profile of Plaistow South Big Local Area

Why so blue? The determinants of color pattern in killifish, Part II Featured scientist: Becky Fuller from The University of Illinois

Department for Transport

Figure 39. Yearly Trend in Death Rates for Drowning: NSW, Year

Football. English for THE GAMES

(Under the Direction of Cheolwoo Park) ABSTRACT. Major League Baseball is a sport complete with a multitude of statistics to evaluate a player s

Self-declaration by New Zealand of its status of freedom from Equine Viral Arteritis

Math 1040 Exam 2 - Spring Instructor: Ruth Trygstad Time Limit: 90 minutes

of 6. Module 5 Ratios, Rates, & Proportions Section 5.1: Ratios and Rates MAT001 MODULE 5 RATIOS, RATES, & PROPORTIONS.

Joint Strategic Needs Assessment (JSNA) Picture of Lewisham 2018

«OKEANOS MASTERS INTERNATIONAL MEETING 2017» 3 rd GREEK MASTERS SWIMMING SERIES GMA SWIMMING SERIES MEETING INFORMATION

An application of the Safe System Approach to a set of self-reported cycling crashes

* A New Species of Cichlid Fish From Lake Malawi. Pseudotropheus tursiops, \(I75 Tropical Fish Hobbyist a'l (3) : 8 L-? 0. ,$ IOU.

Cabrillo College Transportation Study

ASA LONDON REGION GENERAL CONDITIONS

Hierarchical ORAM Revisited, and Applications to Asymptotically Efficient ORAM and OPRAM. Hubert Chan, Yue Guo, Wei-Kai Lin, Elaine Shi 2017/12/5

Robust specification testing in regression: the FRESET test and autocorrelated disturbances

STAT 101 Assignment 1

Target Shooting by Hunters and Their Use of Shooting Ranges: 1975, 1991, and 2011

Money Lost or Won -$5 +$3 +$7

A comparison of two numbers is called a ratio.

AP Stats Chapter 2 Notes

Grid Generation for Screw Compressors with Variable Geometry Rotors

A Dusky Hypoxic Woman. Craig Smollin MD Associate Medical Director California Poison Control Center - SF Div.

Clinical Study Synopsis

Can Economic Pressure Overcome Social Norms? The Case of Female Labor Force Participation

Road Traffic Estimates

Statistics. Wednesday, March 28, 2012

«Hellenic Master International Swimming Championships» 4 th GREEK MASTERS SWIMMING SERIES GMA SWIMMING SERIES-OKEANOS 2018 MEETING INFORMATION

Determining bicycle infrastructure preferences A case study of Dublin

Ch.5 Reliability System Modeling.

Epidemiology of sexually transmitted infections in visitors for the London 2012 Olympic Games: a review of attendees at sexual health services.

The Quality of Life of the People in Norway

Safety Impacts of Road Diets in Iowa

Introduction to Analysis of Variance (ANOVA) The Structural Model, The Summary Table, and the One- Way ANOVA

Pr oject Summar y. Principal Investigators: Walter Cook, Elizabeth Williams, Fred Lindzey, and Ron Grogan. University of Wyoming

European Levels of Investment in Cycling: Results and Insights

Determination of the von Bertalanffy Growth Equation for the Southern New England-Middle Atlantic~ Bank and Gulf of Maine stocks of Silver Hake by

22 Upper Ground, London, SE1 9PD + 44 (0)

Università degli Studi di Firenze


MODELLING THE EFFECT OF HEALTH RISK PERCEPTION ON

A Combined Recruitment Index for Demersal Juvenile Cod in NAFO Divisions 3K and 3L

Evaluation of Cavitation in Hydraulic Turbomachinery Using STAR-CCM+

Neither Don t know

Prior Design for Dependent Dirichlet Processes: An Application to Marathon Modeling

INVASIVE BACTERIAL DISEASE SURVEILLANCE REPORT, 2010

Bathing Water Directive. Ed Beard Defra Bathing Water Conference Southport March 2013

SECTION SEVEN. Characteristics of People with IDD and Staff in Large Public Residential Facilities

Influence of the size of a nation s population on performances in athletics

2011 Census Analysis - Cycling to Work

1. Answer this student s question: Is a random sample of 5% of the students at my school large enough, or should I use 10%?

Simulation of Gas Holdup in a Bubble Column with a Draft Tube for Gas Dispersion into an Annulus

Monitoring of sea trout post-smolts, 2012

Estimating city-level travel patterns using street imagery: a. case study of using Google Street View in Britain

Suicide figures (ABS 2016)

Chapter 5 Wing design - selection of wing parameters - 4 Lecture 22 Topics

PSY201: Chapter 5: The Normal Curve and Standard Scores

Distancei = BrandAi + 2 BrandBi + 3 BrandCi + i

Schwenkiella orietanlis Singh and Agarwal, 1997 (PLATE-XXVII-XXVIII)

Domantas Jasilionis Sustainability of life expectancy improvements in Europe. Demographic Research Centre

THE GENUS PHOTIS (CRUSTACEA: AMPHIPODA) FROM THE TEXAS COAST WITH THE DESCRIPTION OF A NEW SPECIES, PHOTIS MELANICUS

Resistance to Fatigue and Success in Competitive Swimming. Steven C. Myers, Los Alamos High School Jake A. Bailey, University of Northern Colorado

UnitedHealthcare Pharmacy Clinical Pharmacy Programs

SPORTS EVENT SPOTLIGHT. 11 th November 2016

SPORTS EVENT SPOTLIGHT. 24 th February 2017

2017 RELIABILITY STUDY STYLE INSIGHTS

PHYSICAL CHARACTERISTICS OF FEMALE BASKETBALL PLAYERS ACCORDING TO PLAYING POSITION

Travel Patterns and Cycling opportunites

Pacific Blue Marlin Stock Assessment Update in ISC Billfish Working Group

International variations in rates of selected surgical procedures across OECD countries. Klim McPherson and Giorgia Gon

CORRELATION EFFECTS IN THE FIELD CLASSIFICATION OF GROUND BASED REMOTE WIND SENSORS

Primary Schools Competition Brochure. surreycricket.com

WBU WELSH BRIDGE UNION CONGRESS MASTER POINT SCALES NOELLE BOND, WBU MASTER POINTS SECRETARY

Poisoned to Death. Christopher J. Ruhm. University of Virginia and NBER

Which On-Base Percentage Shows. the Highest True Ability of a. Baseball Player?

Book 6. The wee Maths Book. Growth. Grow your brain. N4 Numeracy. of Big Brain. Guaranteed to make your brain grow, just add some effort and hard work

Developing and Supporting the County Age Group Swimmer

1. The data in the following table represent the number of miles per gallon achieved on the highway for compact cars for the model year 2005.

Statistical Modeling of Consumers Participation in Gambling Markets and Frequency of Gambling

Transcription:

Table S1. Comparison between each point and the posterior mean estimates, for each of Risk group size % Males models M1 to M4. The posterior mean deviance is shown in parentheses Data Baseline model Revised NSHPC correction correction + Hierarchical structure Current IL 3.9 4.03 (1) 4.03 (0.9) 4.13 (0.9) 4.14 (0.9) Homosexual OL 0.7 0.81 (1) 0.78 (0.9) 0.80 (1) 0.80 (0.9) GUM attenders REW 0.8 0.80 (1) 0.81 (1) 0.81 (1) 0.80 (1) Current IL 3.4 3.60 (1) 3.60 (0.9) 3.62 (1) 3.62 (1) Homosexuals OL 3.3 3.42 (1) 3.42 (1) 3.44 (1) 3.43 (1) not GUM attenders REW 1.4 1.40 (1) 1.41 (1) 1.41 (1) 1.41 (1) Past Homosexuals IL 0.9 1.16 (1)p 1.15 (1) 1.15 (1.1) 1.16 (1.1) OL 1.2 1.35 (1) 1.35 (1) 1.36 (1) 1.36 (1) REW 0.4 0.39 (1) 0.39 (1) 0.39 (1) 0.39 (1) Current IL 1.1 0.70 (1.4) 0.69 (1.4) 0.69 (1.4) 0.80 (0.8) IDUs OL 1.0 0.49 (2.9) 0.49 (2.9) 0.50 (2.9) 0.57 (1.9) REW 1.2 1.26 (1) 1.25 (1) 1.26 (1) 1.24 (0.9) Past IL 1.1 0.64 (1.7) 0.63 (1.7) 0.64 (1.7) 1.20 (0.9) IDUs OL 0.6 0.27 (2.1) 0.27 (2.1) 0.27 (2.1) 0.67 (0.9) REW 0.7 0.69 (1) 0.69 (1) 0.69 (1) 0.67 (1) GUM IL 10.1 10.20 (1) 10.1 1 (1) 10.23 (1) 10.11 (0.8) OL 7.3 7.36 (1) 7.38 (1) 7.41 (1) 7.52 (0.9) REW 5.0 5.03 (1) 5.02 (1) 5.02 (1) 5.09 (1) SSA IL 8.3 8.32 (1) 8.32 (1) 8.32 (1) 8.32 (1) OL 6.6 6.59 (1) 6.59 (1) 6.59 (1) 6.59 (1) REW 1.0 1.03 (1) 1.03 (1) 1.03 (1) 1.03 (1) Females Current IL 0.3 0.40 (0.7) 0.40 (0.6) 0.37 (0.6) 0.31 (0.3) IDUs OL 0.3 0.39 (0.7) 0.39 (0.7) 0.39 (0.7) 0.20 (0.7) REW 0.4 0.38 (0.9) 0.38 (0.9) 0.38 (0.9) 0.40 (0.9) Past IL 0.5 0.51 (0.6) 0.51 (0.7) 0.53 (0.6) 0.69 (0.8) IDUs OL 0.2 0.31 (0.7) 0.31 (0.7) 0.32 (0.7) 0.36 (0.8) REW 0.2 0.20 (0.9) 0.20 (0.9) 0.20 (0.9) 0.21 (0.9) GUM attenders IL 11.9 12.05 (0.9) 11.7 6 (0.9) 10.98 (1.2) 10.9 (1.1) OL 7.3 7.51 (1) 7.48 (1) 7.28 (1) 7.29 (0.8) REW 5.5 5.49 (1) 5.50 (1) 5.49 (1) 5.44 (1) SSA IL 9.2 9.22 (1.1) 9.21 (1) 9.21 (1) 9.21 (1) OL 7.2 7.20 (1) 7.20 (1) 7.20 (1) 7.20 (1) REW 1.0 1.03 (1) 1.03 (1) 1.03 (1) 1.03 (1) 1

Data Baseline model Revised NSHPC correction correction + Hierarchical structure Seroprevalence % Current Male IDUs IL 6.02 3.3 (3.5) 3.3 (3.4) 3.3 (3.4) 4.5 (1.4) OL 4.73 1.94 (6.2) 1.96 (6.1) 1.95 (6.2) 2.13 (5.1) REW 0.24 0.26 (0.1) 0.26 (0.1) 0.26 (0.1) 0.29 (0.6) Current Female IL 4.76 3.49 (0.7) 3.49 (0.7) 3.41 (0.7) 5.55 (0.3) IDUs OL 1.41 0.85 (0.5) 0.86 (0.5) 0.87 (0.5) 2.64 (0.7) REW 0.37 0.41 (0.1) 0.41 (0.1) 0.42 (0.1) 0.36 (0.3) Female SSA IL 2.45 3.96 (34) 3.51 (18.2) 2.43 (0.6) 2.49 (0.6) OL 2.29 3.42 (18.2) 3.02 (8.5) 2.11 (1.2) 2.15 (0.9) REW 1.56 2.94 (11.6) 2.59 (7.1) 1.67 (0.4) 1.72 (0.5) Female IL 0.09 0.15 (7.5) 0.14 (6) 0.14 (4.7) 0.14 (4.9) non-ssa OL 0.06 0.07 (1.3) 0.07 (0.6) 0.06 (0.4) 0.06 (0.4) REW 0.02 0.03 (1.2) 0.02 (0.3) 0.02 (0.4) 0.02 (0.5) All Females IL 0.39 0.50 (4.2) 0.45 (1.5) 0.43 (0.8) 0.43 (0.7) Prevalence of undiagnosed HIV % OL 0.26 0.31 (1.8) 0.28 (0.4) 0.27 (0.3) 0.26 (0.2) REW 0.04 0.06 (10.7) 0.05 (3.7) 0.04 (0.9) 0.04 (0.9) Homosexuals IL 4.57 4.68 (1) 4.68 (1) 4.68 (1) 4.67 (1) GUM attenders OL 3.51 4.02 (0.8) 4.01 (0.8) 4.05 (0.8) 4.11 (0.8) REW 1.97 1.64 (1) 1.64 (1) 1.64 (1) 1.63 (1) Male IL 0.43 0.49 (1) 0.49 (1) 0.49 (1) 0.43 (1) GUM attenders OL 0.17 0.21 (0.9) 0.21 (0.9) 0.22 (0.9) 0.26 (0.7) REW 0.09 0.08 (1) 0.08 (1) 0.08 (1) 0.08 (0.6) Female IL 0.32 0.33 (0.9) 0.33 (0.9) 0.30 (1.4) 0.33 (0.8) GUM attenders OL 0.20 0.27 (1) 0.26 (0.9) 0.25 (0.7) 0.20 (0.4) REW 0.07 0.06 (1) 0.06 (1.1) 0.06 (1) 0.06 (0.6) Proportion reported diagnosed % Male Current Il 69 68 (1.1) 68 (1.1) 68 (1.1) 66 (1.6) IDUs OL 53 51 (1.1) 51 (1.1) 51 (1.1) 56 (1.3) REW 52 51 (1) 51 (1) 51 (1) 51 (1) Female Il 60 59 (1) 59 (1) 60 (0.9) 70 (2.3) Current OL 73 72 (1) 72 (1) 72 (1) 63 (3.5) IDUs REW 56 56 (1) 56 (1) 56 (1) 57 (0.9) Female SSA IL 40, 58 59 (28.9) 68 (8.8) 59 (0.9) 59 (0.9) OL 30, 47 50 (23.7) 58 (7) 45 (1) 45 (1) REW 13, 29 39 (32.9) 45 (9.6) 33 (1.1) 32 (1) Female IL 36, 46 54 (6.5) 57 (2.8) 46 (0.6) 44 (0.6) not- SSA OL 27, 37 41 (2.6) 44 (1.1) 35 (0.6) 35 (0.6) REW 26, 38 41 (6.8) 47 (2.8) 39 (0.8) 39 (0.8) 2

Data Baseline model Revised NSHPC correction correction + Hierarchical structure SOPHID Males Fraction of cases, % Homosexual IL 81 80 (1) 80 (1) 80 (1) 81 (0.9) OL 58 57 (1) 57 (1) 57 (1) 57 (1) REW 71 71 (1) 71 (1) 71 (1) 71 (0.9) IDUs IL 15 15 (1.1) 15 (1.1) 15 (1.1) 15 (1) OL 8 8 (1.4) 8 (1.4) 8 (1.4) 8 (1.1) REW 17 17 (1) 17 (1) 17 (1) 17 (1) SSA IL 68 68 (1) 68 (1) 68 (1) 68 (1) OL 70 70 (1) 70 (1) 70 (1) 70 (0.9) REW 37 37 (1) 37 (1) 37 (1) 37 (0.9) Total cases, counts IL 6237 6244 (1) 6243 (1) 6243 (1) 6237 (1) OL 1790 1798 (1) 1798 (1) 1797 (1) 1800 (1) REW 5054 5056 (1) 5056 (1) 5056 (1) 5055 (1) Females Fraction of cases, % SSA IL 6 6 (1.1) 6 (1) 6 (1) 6 (1) OL 2.2 2 (1.1) 2 (1) 2 (1) 2 (1) REW 6 6 (1) 6 (1) 6 (1) 6 (1) IDUs IL 80 79 (1.2) 79 (1) 80 (1) 80 (1) OL 84 84 (1.1) 84 (1) 84 (1) 84 (0.9) REW 56 56 (1.3) 56 (1.1) 56 (1) 56 (1) Total cases, counts IL 2087 1981 (6.5) 2014 (3.5) 2078 (1) 2079 (0.9) OL 1441 1382 (3.5) 1407 (1.8) 1452 (1) 1446 (0.9) REW 1876 1819 (2.8) 1843 (1.6) 1872 (1) 1873 (0.9) NOTE. IL: Inner London, OL: Outer London and REW: Rest of England and Wales 3

Table S2. Posterior mean (standard deviation) of risk group size, prevalence, prevalence of undiagnosed infection and probability of diagnosis. Baseline model correction correction + Group size, % Males Male Homosexuals IL 8.8 (1.6) 8.78 (1.53) 8.90 (1.59) 8.92 (1.58) OL 5.6 (1.1) 5.56 (1.06) 5.60 (1.05) 5.59 (1.05) REW 2.6 (0.2) 2.60 (0.25) 2.60 (0.25) 2.59 (0.24) Current IL 4.1 (1.1) 4.03 (1.03) 4.13 (1.08) 4.14 (1.06) Homosexual OL 0.8 (0.4) 0.78 (0.39) 0.80 (0.41) 0.80 (0.39) GUM attenders REW 0.8 (0.1) 0.81 (0.14) 0.81 (0.14) 0.80 (0.14) Current IL 3.6 (1) 3.60 (0.98) 3.62 (1.02) 3.62 (1.02) Homosexuals OL 3.5 (0.8) 3.42 (0.83) 3.44 (0.82) 3.43 (0.82) not GUM attenders REW 1.4 (0.2) 1.41 (0.18) 1.41 (0.18) 1.41 (0.18) Past IL 1.2 (0.6) 1.15 (0.58) 1.15 (0.59) 1.16 (0.59) Homosexuals OL 1.4 (0.5) 1.35 (0.52) 1.36 (0.53) 1.36 (0.53) REW 0.4 (0.1) 0.39 (0.09) 0.39 (0.09) 0.39 (0.09) All IDUs IL 1.3 (0.5) 1.33 (0.47) 1.33 (0.47) 2.00 (0.62) OL 0.8 (0.3) 0.76 (0.31) 0.77 (0.31) 1.24 (0.41) REW 1.9 (0.2) 1.94 (0.21) 1.95 (0.21) 1.92 (0.2) Current IL 0.7 (0.3) 0.69 (0.34) 0.69 (0.33) 0.80 (0.29) IDUs OL 0.5 (0.2) 0.49 (0.23) 0.50 (0.24) 0.57 (0.22) REW 1.3 (0.2) 1.25 (0.17) 1.26 (0.17) 1.24 (0.16) Past IL 0.6 (0.3) 0.63 (0.31) 0.64 (0.31) 1.20 (0.58) IDUs OL 0.3 (0.2) 0.27 (0.16) 0.27 (0.16) 0.67 (0.36) REW 0.7 (0.1) 0.69 (0.12) 0.69 (0.13) 0.67 (0.12) GUM IL 10.2 (1.7) 10.11 (1.63) 10.2 3 (1.66) 10.11 (1.49) attenders OL 7.4 (1.2) 7.38 (1.18) 7.41 (1.18) 7.52 (1.13) REW 5.0 (0.3) 5.02 (0.33) 5.02 (0.33) 5.09 (0.33) SSA IL 8.3 (0.03) 8.32 (0.032) 11.6 9 (0.88) 11.28 (0.89) OL 6.6 (0.03) 6.59 (0.025) 9.32 (0.72) 8.99 (0.72) REW 1.0 (3) 1.03 (3) 1.50 (0.13) 1.44 (0.13) Females All IDUs IL 0.9 (0.4) 0.91 (0.44) 0.89 (0.43) 1.00 (0.42) OL 0.7 (0.4) 0.70 (0.36) 0.71 (0.37) 0.56 (0.27) REW 0.6 (0.1) 0.58 (0.11) 0.58 (0.11) 0.61 (0.11) Current IL 0.4 (0.3) 0.40 (0.29) 0.37 (0.27) 0.31 (0.16) IDUs OL 0.4 (0.3) 0.39 (0.26) 0.39 (0.26) 0.20 (0.1) REW 0.4 (0.1) 0.38 (0.09) 0.38 (0.09) 0.40 (0.09) Past IL 0.5 (0.3) 0.51 (0.33) 0.53 (0.32) 0.69 (0.42) IDUs OL 0.3 (0.2) 0.31 (0.23) 0.32 (0.23) 0.36 (0.26) REW 0.2 (0.1) 0.20 (0.07) 0.20 (0.07) 0.21 (0.07) 4

Baseline model correction correction + GUM IL 12.0 (1.7) 11.76 (1.7) 10.9 8 (1.63) 10.90 (1.46) attenders OL 7.5 (1.2) 7.48 (1.23) 7.28 (1.21) 7.29 (1.11) REW 5.5 (0.4) 5.50 (0.36) 5.49 (0.36) 5.44 (0.35) SSA IL 9.2 (0.03) 9.21 (0.033) 12.8 8 (0.95) 12.43 (0.96) OL 7.2 (0.03) 7.20 (0.026) 10.1 6 (0.77) 9.79 (0.78) REW 1.0 (3) 1.03 (3) 1.49 (0.13) 1.44 (0.13) Prevalence, % Male Homosexuals IL 12.2 (1.8) 12.2 (1.7) 12.2 (1.7) 12.2 (1.7) OL 3.9 (1.3) 3.9 (1.2) 3.9 (1.2) 4.0 (1.2) REW 2.7 (0.3) 2.7 (0.3) 2.7 (0.3) 2.7 (0.3) Current IL 15.8 (7.5) 15.9 (7.3) 14.9 (7) 15.2 (7.3) Homosexual OL 14.4 (9.4) 14.2 (9.7) 14.0 (9.6) 13.6 (7.8) GUM attenders REW 4.4 (1.9) 4.4 (1.8) 4.4 (1.9) 4.7 (1.9) Current IL 11.7 (7.8) 11.8 (7.7) 12.8 (8.1) 12.1 (8.2) Homosexuals OL 3.0 (1.8) 3.1 (1.8) 3.0 (1.8) 3.1 (1.8) not GUM attenders REW 2.3 (1) 2.3 (1.1) 2.2 (1.1) 2.1 (1.1) Past IL 3.5 (10.1) 2.8 (7.2) 2.97 (7.27) 4.09 (11.67) Homosexuals OL 1.4 (1.6) 1.3 (1.6) 1.48 (1.91) 1.39 (1.61) REW 0.6 (0.9) 0.7 (1.1) 0.72 (1.12) 0.64 (0.88) All IL 3.3 (1.1) 3.32 (1.18) 3.33 (1.16) 2.31 (0.74) IDUs OL 2.0 (0.8) 1.96 (0.78) 1.95 (0.78) 1.10 (0.39) REW 0.3 (0.04) 0.26 (0.04) 0.26 (0.04) 0.28 (0.04) Current IL 3.3 (1.1) 3.32 (1.18) 3.33 (1.16) 4.49 (1.37) IDUs OL 2.0 (0.8) 1.96 (0.78) 1.95 (0.78) 2.13 (0.77) REW 0.3 (0) 0.26 (0.04) 0.26 (0.04) 0.29 (0.09) Past IL 3.3 (1.1) 3.32 (1.18) 3.33 (1.16) 0.86 (0.76) IDUs OL 2.0 (0.8) 1.96 (0.78) 1.95 (0.78) 0.26 (0.29) REW 0.3 (0) 0.3 (0.04) 0.26 (0.04) 0.3 (0.14) GUM IL 0.9 (0.2) 0.9 (0.18) 0.92 (0.17) 0.78 (0.18) attenders OL 0.4 (0.2) 0.4 (0.18) 0.46 (0.18) 0.45 (0.16) REW 0.2 (0.1) 0.2 (0.06) 0.20 (0.06) 0.18 (0.07) SSA IL 2.9 (0.2) 2.4 (0.14) 1.56 (0.13) 1.41 (0.16) OL 2.5 (0.2) 2.1 (0.16) 1.41 (0.14) 1.19 (0.17) REW 2.4 (0.3) 2.0 (0.21) 1.22 (0.16) 0.95 (0.16) Low Risk IL 0.04 (0.029) 0.030 (0.025) OL 0.04 (0.02) 0.029 (0.018) 0.01 8 (0.02) 0.032 (0.025) 0.01 9 (0.015) 0.026 (0.017) 5

Baseline model correction correction + REW 0.02 (5) 0.014 (4) 8 (5) 0.010 (6) Female All IDUs IL 3.5 (1.8) 3.5 (1.83) 3.41 (1.76) 2.8 (1.15) OL 0.9 (0.5) 0.9 (0.53) 0.87 (0.55) 1.2 (0.6) REW 0.4 (0.1) 0.4 (0.09) 0.42 (0.1) 0.4 (0.08) Current IL 3.5 (1.8) 3.49 (1.83) 3.41 (1.76) 5.55 (1.88) IDUs OL 0.9 (0.5) 0.86 (0.53) 0.87 (0.55) 2.64 (1.04) REW 0.4 (0.1) 0.41 (0.09) 0.42 (0.1) 0.36 (0.13) Past IL 3.5 (1.8) 3.49 (1.83) 3.41 (1.76) 1.41 (1.29) IDUs OL 0.9 (0.5) 0.86 (0.53) 0.87 (0.55) 0.43 (0.54) REW 0.4 (0.1) 0.41 (0.09) 0.42 (0.1) 0.43 (0.27) GUM IL 0.6 (0.2) 0.63 (0.18) 0.65 (0.19) 0.68 (0.17) attenders OL 0.4 (0.2) 0.44 (0.17) 0.45 (0.17) 0.39 (0.14) REW 0.1 (0.1) 0.14 (0.06) 0.16 (0.06) 0.16 (0.06) SSA IL 4.0 (0.2) 3.51 (0.14) 2.43 (0.16) 2.49 (0.17) OL 3.4 (0.2) 3.02 (0.16) 2.11 (0.16) 2.15 (0.16) REW 2.9 (0.3) 2.59 (0.21) 1.67 (0.18) 1.72 (0.18) Low Risk IL 0.05 (0.03) 0.04 (0.027) 0.03 3 (0.026) 0.032 (0.024) OL 0.04 (0.019) 0.03 (0.016) 0.02 2 (0.014) 0.025 (0.014) REW 0.02 (5) 0.01 (4) 9 (4) 0.010 (4) Prevalence Undiagnosed HIV, % Male Homosexuals IL 3.15 (0.49) 3.15 (0.48) 3.17 (0.48) 3.16 (0.48) OL 1.76 (1.15) 1.70 (1.1) 1.74 (1.12) 1.76 (1.14) REW 0.92 (0.25) 0.92 (0.25) 0.91 (0.24) 0.91 (0.25) Current IL 4.68 (0.49) 4.68 (0.49) 4.68 (0.49) 4.67 (0.49) Homosexual OL 4.07 (2.34) 4.01 (2.31) 4.05 (2.35) 4.11 (2.34) GUM attenders REW 1.64 (0.32) 1.64 (0.32) 1.64 (0.32) 1.63 (0.32) Current IL 2.29 (0.59) 2.29 (0.58) 2.29 (0.59) 2.28 (0.57) Homosexuals OL 1.75 (1.3) 1.69 (1.23) 1.71 (1.24) 1.74 (1.29) not GUM attenders REW 0.71 (0.33) 0.70 (0.34) 0.70 (0.32) 0.70 (0.33) Past IL 0.50 (0.13) 0.50 (0.12) 0.50 (0.12) 0.50 (0.12) Homosexuals OL 0.44 (0.28) 0.43 (0.28) 0.44 (0.29) 0.44 (0.29) REW 0.17 (0.05) 0.17 (0.05) 0.17 (0.05) 0.17 (0.05) All IDUs IL 0.84 (0.38) 0.86 (0.39) 0.86 (0.39) 0.72 (0.27) OL 0.84 (0.38) 0.84 (0.37) 0.83 (0.38) 0.47 (0.18) REW 0.11 (0.03) 0.11 (0.03) 0.11 (0.03) 0.12 (0.03) Current IL 1.05 (0.4) 1.06 (0.41) 1.06 (0.41) 1.55 (0.51) IDUs OL 0.96 (0.4) 0.95 (0.4) 0.95 (0.4) 0.95 (0.36) 6

Baseline model correction correction + REW 0.13 (0.02) 0.13 (0.02) 0.13 (0.02) 0.14 (0.05) Past IL 0.61 (0.41) 0.63 (0.42) 0.62 (0.42) 0.16 (0.2) IDUs OL 0.61 (0.39) 0.61 (0.39) 0.61 (0.39) 0.06 (0.1) REW 0.07 (0.04) 0.07 (0.04) 0.07 (0.04) 0.08 (0.07) GUM IL 0.49 (0.09) 0.49 (0.09) 0.49 (0.09) 0.43 (0.07) attenders OL 0.21 (0.13) 0.21 (0.13) 0.22 (0.13) 0.26 (0.1) REW 0.08 (0.02) 0.08 (0.02) 0.08 (0.02) 0.08 (0.02) SSA IL 1.62 (0.16) 1.12 (0.13) 0.62 (0.11) 0.45 (0.14) OL 1.70 (0.18) 1.26 (0.15) 0.80 (0.14) 0.55 (0.16) REW 1.82 (0.28) 1.43 (0.2) 0.84 (0.15) 0.56 (0.15) Low Risk IL 0.02 (0.016) 0.013 (0.011) Female OL 0.03 (0.015) 0.018 (0.012) 0.01 REW 2 (4) 9 (3) 7 (7) 7 (8) 0.01 0 (8) 0.013 (0.011) 5 (2) 5 (3) All IDUs IL 1.12 (0.74) 1.08 (0.73) 0.94 (0.64) 0.68 (0.36) OL 0.19 (0.14) 0.19 (0.14) 0.19 (0.15) 0.42 (0.23) REW 0.15 (0.05) 0.15 (0.05) 0.16 (0.05) 0.14 (0.04) Current IL 1.46 (0.83) 1.45 (0.84) 1.36 (0.77) 1.66 (0.62) IDUs OL 0.24 (0.16) 0.24 (0.16) 0.24 (0.17) 0.98 (0.41) REW 0.18 (0.04) 0.18 (0.04) 0.18 (0.04) 0.16 (0.06) Past IL 0.82 (0.7) 0.79 (0.69) 0.64 (0.6) 0.20 (0.26) IDUs OL 0.13 (0.12) 0.13 (0.12) 0.13 (0.13) 0.09 (0.14) REW 0.10 (0.06) 0.10 (0.06) 0.10 (0.06) 0.10 (0.1) GUM IL 0.34 (0.07) 0.33 (0.06) 0.30 (0.06) 0.33 (0.05) attenders OL 0.26 (0.12) 0.26 (0.11) 0.25 (0.1) 0.20 (0.08) REW 0.06 (0.02) 0.06 (0.02) 0.06 (0.02) 0.06 (0.02) SSA IL 1.62 (0.16) 1.12 (0.13) 0.62 (0.11) 0.62 (0.11) OL 1.70 (0.18) 1.26 (0.15) 0.80 (0.14) 0.80 (0.14) REW 1.82 (0.28) 1.43 (0.2) 0.84 (0.15) 0.86 (0.16) Low Risk IL 0.02 (0.016) 0.013 (0.011) 7 (7) 6 (6) OL 0.03 (0.015) 0.018 (0.012) 0.01 0 (8) 0.011 (9) REW 0.01 (4) 9 (3) 5 (2) 5 (2) Proportion diagnosed, % Male Homosexuals IL 74 (5) 74 (4) 74 (4) 74 (4) OL 59 (15) 60 (15) 59 (14) 59 (15) REW 66 (6) 66 (6) 66 (6) 66 (6) Current IL 62 (21) 62 (21) 60 (22) 60 (22) Homosexual OL 63 (24) 62 (25) 62 (24) 62 (24) 7

Baseline model correction correction + GUM attenders REW 56 (21) 55 (21) 55 (22) 58 (21) Current IL 68 (24) 68 (24) 71 (23) 68 (24) Homosexuals OL 39 (23) 42 (24) 41 (23) 41 (23) not GUM attenders REW 61 (22) 62 (22) 61 (23) 59 (23) Past IL 50 (29) 50 (29) 50 (29) 52 (30) Homosexuals OL 48 (28) 48 (28) 49 (28) 48 (28) REW 49 (28) 49 (28) 50 (29) 49 (28) IDUs IL 74 (6) 74 (6) 75 (6) 69 (5) OL 57 (6) 57 (6) 58 (6) 58 (5) REW 60 (5) 60 (5) 60 (5) 58 (6) Current IL 68 (4) 68 (4) 68 (4) 66 (4) IDUs OL 51 (4) 51 (4) 51 (4) 56 (4) REW 51 (1) 51 (1) 51 (1) 51 (1) Past IL 82 (9) 81 (9) 82 (10) 82 (10) IDUs OL 69 (14) 69 (14) 69 (14) 77 (13) REW 75 (14) 75 (14) 75 (14) 73 (14) GUM IL 41 (13) 43 (13) 46 (11) 42 (14) attenders OL 47 (21) 49 (20) 53 (19) 40 (17) REW 49 (20) 51 (20) 57 (18) 50 (21) SSA IL 44 (3) 54 (3) 60 (5) 69 (7) OL 33 (3) 40 (3) 44 (5) 55 (7) REW 23 (3) 28 (3) 31 (4) 42 (7) Low Risk IL 43 (25) 46 (26) 49 (27) 69 (26) OL 35 (21) 38 (22) 44 (25) 50 (25) REW 29 (15) 33 (17) 41 (22) 42 (22) Female IDUs IL 69 (10) 70 (10) 73 (9) 76 (6) OL 78 (7) 78 (7) 78 (7) 67 (6) REW 63 (5) 63 (5) 63 (5) 65 (7) Current IDUs IL 59 (7) 59 (7) 60 (7) 70 (4) OL 72 (6) 72 (6) 72 (5) 63 (4) REW 56 (2) 56 (2) 56 (2) 57 (2) Past IL 77 (13) 78 (13) 82 (12) 86 (9) IDUs OL 86 (9) 86 (9) 86 (9) 81 (11) REW 77 (13) 77 (13) 77 (13) 78 (12) GUM IL 41 (17) 44 (17) 50 (17) 49 (15) attenders OL 37 (18) 38 (18) 42 (18) 45 (18) REW 47 (21) 50 (21) 53 (20) 55 (21) SSA IL 59 (2) 68 (2) 74 (4) 75 (4) OL 50 (3) 58 (3) 62 (5) 63 (5) REW 39 (4) 45 (4) 50 (5) 50 (5) 8

Baseline model correction correction + Low Risk IL 58 (25) 62 (26) 71 (25) 73 (25) OL 38 (22) 44 (23) 56 (26) 55 (25) REW 31 (15) 36 (17) 49 (22) 47 (23) 9

Table S3. Posterior means (standard deviation) of Ssupplementary parameters, ν, λ, α, ε Priors Baseline NSHPC Adjusted Both SSA corrections correction + Hierarchical structure Overall SOPHID incompleteness, ν (%) ν ~ Beta(183.9,1487.7) 9.8 (0.7) 10.2 (0.7) 11.1 (0.8) 11.1 (0.8) LOR of effective proportion diagnosed to reported diagnosed (sd), λ Log(λ) ~ Normal(0,10000) 0.73 (0.16) 0.75 (0.17) LOR effective to Census estimate Size (sd), ε Log(ε) ~ Normal(0,10000) 0.37 (0.08) 0.33 (0.09) 10